김한준 (서울대학교 의과대학, 서울대학교병원)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학, 서울대학교병원

최종업데이트 2022.08.02.

GLP1R expression and parkinson's disease and related disorders in GLP-1RA-treated type 2 diabetes
- Brain, Apr 10 2026, awag130 | https://doi.org/10.1093/brain/awag130
- 2026-04
- 한빛사논문
Whole-brain dopamine transporter binding pattern predicts survival in multiple system atrophy
- Transl. Neurodegener., Apr 02 2024, 13 (1) | https://doi.org/10.1186/s40035-024-00411-2
- 2024-04
- 의약학
- 한빛사논문
Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease
- Mov. Disord., First published: 21 May 2022 | https://doi.org/10.1002/mds.29056
- 2022-05
- 의약학
- 한빛사논문
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
- J. Mov. Disord., Jan 2020, 13(1): 11-19 | DOI: https://doi.org/10.14802/jmd.19057
- 2020-01
- 의약학
- 구.추천논문

연구자 ID

저자논문